BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/20/2015 9:13:00 AM | Browse: 1170 | Download: 1286
Publication Name World Journal of Diabetes
Manuscript ID 13979
Country United States
Received
2014-09-11 08:09
Peer-Review Started
2014-09-11 09:39
To Make the First Decision
2014-11-14 18:51
Return for Revision
2014-11-19 16:56
Revised
2014-11-26 02:27
Second Decision
2015-01-04 16:00
Accepted by Journal Editor-in-Chief
2015-01-05 10:54
Accepted by Company Editor-in-Chief
2015-01-12 14:34
Articles in Press
2015-01-12 14:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-04-03 15:22
Publish the Manuscript Online
2015-04-20 09:13
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Review
Article Title Type 1 diabetes: A predictable disease
Manuscript Source Invited Manuscript
All Author List Kimber M Simmons and Aaron W Michels
Funding Agency and Grant Number
Funding Agency Grant Number
National Institute of Diabetes and Digestive Kidney Diseases R01 DK032083
National Institute of Diabetes and Digestive Kidney Diseases K08 DK095995
Juvenile Diabetes Research Foundation
Children’s Diabetes Foundation
Brehm Coalition
Corresponding Author Aaron W Michels, MD, Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Mail Stop A140, 1775 Aurora Court, Aurora, CO 80045, United States. aaron.michels@ucdenver.edu
Key Words Autoimmunity; Autoantibodies; Diabetes prevention; Screening; Type 1 diabetes
Core Tip Type 1 diabetes (T1D), the immune mediated form of diabetes, is now a predictable disease with the measurement of islet autoantibodies. The presence of two or more antibodies defines preclinical disease as nearly everyone with multiple antibodies progresses to clinical diabetes. With improved platforms to measure islet autoantibodies, screening the general population is now a goal. Early identification of preclinical diabetes allows for less diabetic ketoacidosis, early initiation of insulin therapy, and the potential to delay or prevent diabetes onset. Clinical trials using safe and specific therapies to block disease specific immune cells are underway in T1D.
Publish Date 2015-04-20 09:13
Citation Simmons KM, Michels AW. Type 1 diabetes: A predictable disease. World J Diabetes 2015; 6(3): 380-390
URL http://www.wjgnet.com/1948-9358/full/v6/i3/380.htm
DOI http://dx.doi.org/10.4239/wjd.v6.i3.380
Full Article (PDF) WJD-6-380.pdf
Full Article (Word) WJD-6-380.doc
Manuscript File 13979-Review.docx
Answering Reviewers 13979-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 13979-Conflict-of-interest statement.pdf
Copyright License Agreement 13979-Copyright assignment.pdf
Peer-review Report 13979-Peer review(s).pdf
Scientific Misconduct Check 13979-CrossCheck.jpg
Scientific Editor Work List 13979-Scientific editor work list.pdf